Real world multicenter prospective study of combination therapy of anti-fibrotic agents in idiopathic pulmonary fibrosis(J-AVENGERS)
Not Applicable
Recruiting
- Conditions
- idiopathic pulmonary fibrosis
- Registration Number
- JPRN-UMIN000039027
- Lead Sponsor
- Japanese Red Cross Medical Canter
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with FEV1/FVC < 0.7 2)Patients who have treated with combination therapy of anti-fibrotic agents 3)Patients who require fibrinolysis, full-dose therapeutic anticoagulation, or high dose antiplatelet therapy 4)Patients who had acute exacerbation of IPF within 6 months 5)Patients who have uncontrolled complications (unstable angina, acute myocardial infarction, severe bronchial asthma, heart failure, bleeding tendency) 6)Patients who cannot perform pulmonary function test 7)Patients who are pregnant 8)Other patients who are judged to be inappropriate as a target by the doctor's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method